Drug intelligence / Profile preview

Provacel

Development stage
Approved
Lead developer
Smith & Nephew
Modality
Mesenchymal Stem Cells → Adult Stem Cells → Stem Cell Therapies → Cell Therapies
Administration
Intravenous
01

Overview

Provacel is an investigational therapy consisting of adult mesenchymal stem cells (MSCs) derived from healthy donors. It has been studied primarily for the treatment of acute myocardial infarction (AMI), where it is administered to improve cardiac function following heart attacks. Clinical studies have shown that patients receiving Provacel experienced significant improvements in cardiac ejection fraction and pulmonary function compared to placebo. The proposed mechanism involves the anti-inflammatory and anti-fibrotic properties of MSCs, which may also benefit conditions such as chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF). Developed by Osiris Therapeutics, Provacel represents a cell-based regenerative medicine approach aimed at tissue repair and modulation of immune responses[2][3][7].

Brand names
Provacel
Other names
Provaceladult mesenchymal stem cellsMSCs

Beyond the preview

Go deeper on Provacel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Provacel.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call